Related Experiment Video
Updated: Jul 29, 2026
Rapid and Refined CD11b Magnetic Isolation of Primary Microglia with Enhanced Purity and Versatility
Published on: April 13, 2017
Allogenic microglia replacement: A novel therapeutic strategy for neurological disorders
Yanxia Rao1, Bo Peng2,3
1Department of Laboratory Animal Science, MOE Frontiers Center for Brain Science, Fudan University, Shanghai 200032, China.
Abstract:
Microglia are resident immune cells in the central nervous system (CNS) that play vital roles in CNS development, homeostasis and disease pathogenesis. Genetic defects in microglia lead to microglial dysfunction, which in turn leads to neurological disorders. The correction of the specific genetic defects in microglia in these disorders can lead to therapeutic effects. Traditional genetic defect correction approaches are dependent on viral vector-based genetic defect corrections. However, the viruses used in these approaches, including adeno-associated viruses, lentiviruses and retroviruses, do not primarily target microglia; therefore, viral vector-based genetic defect corrections are ineffective in microglia. Microglia replacement is a novel approach to correct microglial genetic defects via replacing microglia of genetic defects with allogenic healthy microglia. In this paper, we systematically review the history, rationale and therapeutic perspectives of microglia replacement, which would be a novel strategy for treating CNS disorders.
Insights
Microglia replacement offers a new way to treat neurological disorders caused by genetic defects in these immune cells. This approach replaces faulty microglia with healthy ones, overcoming limitations of traditional viral gene therapies.
Area of Science:
- Neuroscience
- Immunology
- Genetics
Background:
- Microglia, the central nervous system's immune cells, are crucial for brain development, homeostasis, and disease.
- Genetic defects in microglia cause dysfunction and lead to neurological disorders.
- Current gene correction methods using viral vectors are inefficient for microglia.
Purpose of the Study:
- To review the novel strategy of microglia replacement for treating central nervous system (CNS) disorders.
- To explore the history, rationale, and therapeutic potential of microglia replacement therapy.
Main Methods:
- Systematic review of existing literature on microglia replacement.
- Analysis of the limitations of viral vector-based gene therapies in microglia.
- Evaluation of the concept of allogeneic microglia transplantation.
Main Results:
- Microglia replacement is a promising alternative to viral gene therapy for genetic microglial defects.
- This method involves replacing diseased microglia with healthy, donor-derived microglia.
- It addresses the challenge of targeting microglia effectively for genetic correction.
Conclusions:
- Microglia replacement presents a novel therapeutic strategy for CNS disorders stemming from microglial genetic defects.
- This approach bypasses the inefficacy of traditional viral vectors in microglia.
- Further research into microglia replacement holds significant therapeutic promise for neurological diseases.
More Related Videos
10:21Characterization and Isolation of Mouse Primary Microglia by Density Gradient Centrifugation
Published on: February 16, 2018
06:12Author Spotlight: Induced Microglia-Like Cell Technology to Shed Light on the Role of Microglial Dysfunction in Neuropsychiatric Disorders
Published on: September 6, 2024
